{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T00:06:01Z","timestamp":1747181161030,"version":"3.40.5"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"46","license":[{"start":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T00:00:00Z","timestamp":1700179200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,11,17]]},"abstract":"<jats:p>Evidence supporting a starting dose of 2\u2009g\/day of mycophenolate mofetil (MMF) in combination with tacrolimus (TAC) for renal transplantation (RT) is still limited, but maintaining a dose of &lt;2\u2009g could result in worse clinical outcomes in terms of acute rejection (AR). This study aimed to determine the association between AR and infectious and noninfectious complications after RT with a dose of 1.5\u2009g <jats:italic toggle=\"yes\">vs<\/jats:italic> 2\u2009g of MMF. A prospective cohort study was performed with a 12-month follow-up of recipients of RT from living donors with low (1.5\u2009g\/day) or standard (2\u2009g\/day) doses of MMF. The association between adverse effects and complications and doses of MMF was examined using Cox proportional hazard models, and survival free of AR, infectious diseases, and noninfectious complications was evaluated using the Kaplan\u2013Meier test. At the end of the follow-up, the incidence of infectious diseases was 52% versus 50% (<jats:italic toggle=\"yes\">P<\/jats:italic> = .71) and AR was 5% versus 5% (<jats:italic toggle=\"yes\">P<\/jats:italic> = .86), respectively. The survival rate free of gastrointestinal (GI) complications requiring medical attention was higher in the low-dose group than in the standard-dose dose (88% vs 45%, respectively; <jats:italic toggle=\"yes\">P<\/jats:italic> &lt; .001). The use of 1.5\u2009g\/day of MMF confers a reduction in GI complications without an increase in infectious diseases or the risk of AR.<\/jats:p>","DOI":"10.1097\/md.0000000000035841","type":"journal-article","created":{"date-parts":[[2023,11,28]],"date-time":"2023-11-28T09:19:49Z","timestamp":1701163189000},"page":"e35841","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Clinical impact using low-dose mycophenolate mofetil with tacrolimus on infectious, noninfectious complications and acute rejection, in renal transplant: A single hospital experience in Mexico"],"prefix":"10.1097","volume":"102","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1663-8223","authenticated-orcid":false,"given":"Jorge","family":"Andrade-Sierra","sequence":"first","affiliation":[{"name":"Department of Physiology, University Health Sciences Center, University of Guadalajara, Guadalajara, Jalisco, Mexico"},{"name":"Department of Nephrology and Organ Transplant Unit, Specialties Hospital, National Western Medical Centre, Mexican Institute of Social Security, Guadalajara, Jalisco, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4066-9476","authenticated-orcid":false,"given":"Hernesto","family":"Hern\u00e1ndez-Reyes","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Organ Transplant Unit, Specialties Hospital, National Western Medical Centre, Mexican Institute of Social Security, Guadalajara, Jalisco, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6868-6465","authenticated-orcid":false,"given":"Enrique","family":"Rojas-Campos","sequence":"additional","affiliation":[{"name":"Medical Research Unit in Renal Diseases, Specialties Hospital, National Western Medical Centre, Mexican Institute of Social Security, Guadalajara, Jalisco, Mexico."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7868-667X","authenticated-orcid":false,"given":"Ernesto Germ\u00e1n","family":"Cardona-Mu\u00f1oz","sequence":"additional","affiliation":[{"name":"Department of Physiology, University Health Sciences Center, University of Guadalajara, Guadalajara, Jalisco, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2443-9515","authenticated-orcid":false,"given":"Jos\u00e9 Ignacio","family":"Cerrillos-Guti\u00e9rrez","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Organ Transplant Unit, Specialties Hospital, National Western Medical Centre, Mexican Institute of Social Security, Guadalajara, Jalisco, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo","family":"Gonz\u00e1lez-Espinoza","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Organ Transplant Unit, Specialties Hospital, National Western Medical Centre, Mexican Institute of Social Security, Guadalajara, Jalisco, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5625-9447","authenticated-orcid":false,"given":"Luis Alberto","family":"Evangelista-Carrillo","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Organ Transplant Unit, Specialties Hospital, National Western Medical Centre, Mexican Institute of Social Security, Guadalajara, Jalisco, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7259-4317","authenticated-orcid":false,"given":"Miguel","family":"Medina-P\u00e9rez","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Organ Transplant Unit, Specialties Hospital, National Western Medical Centre, Mexican Institute of Social Security, Guadalajara, Jalisco, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5181-7286","authenticated-orcid":false,"given":"Basilio","family":"Jalomo-Mart\u00ednez","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Organ Transplant Unit, Specialties Hospital, National Western Medical Centre, Mexican Institute of Social Security, Guadalajara, Jalisco, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3635-6135","authenticated-orcid":false,"given":"Alejandra Guillermina","family":"Miranda-D\u00edaz","sequence":"additional","affiliation":[{"name":"Department of Physiology, University Health Sciences Center, University of Guadalajara, Guadalajara, Jalisco, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V\u00edctor Manuel","family":"Mart\u00ednez-Mej\u00eda","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Organ Transplant Unit, Specialties Hospital, National Western Medical Centre, Mexican Institute of Social Security, Guadalajara, Jalisco, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2975-1898","authenticated-orcid":false,"given":"Benjamin","family":"G\u00f3mez-Navarro","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Organ Transplant Unit, Specialties Hospital, National Western Medical Centre, Mexican Institute of Social Security, Guadalajara, Jalisco, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6796-1445","authenticated-orcid":false,"given":"Antonio de Jes\u00fas","family":"Andrade-Ortega","sequence":"additional","affiliation":[{"name":"Department of Physiology, University Health Sciences Center, University of Guadalajara, Guadalajara, Jalisco, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Jos\u00e9","family":"Nieves-Hern\u00e1ndez","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Organ Transplant Unit, Specialties Hospital, National Western Medical Centre, Mexican Institute of Social Security, Guadalajara, Jalisco, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4853-0356","authenticated-orcid":false,"given":"Claudia Alejandra","family":"Mendoza-Cerpa","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Organ Transplant Unit, Specialties Hospital, National Western Medical Centre, Mexican Institute of Social Security, Guadalajara, Jalisco, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"136","DOI":"10.6002\/ect.2021.0356","article-title":"Death with a functioning graft kidney: a single-center experience of more than 4 decades.","volume":"20","author":"Gamal","year":"2022","journal-title":"Exp Clin Transplant"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"e13516","DOI":"10.1111\/ctr.13516","article-title":"Infections after kidney transplantation Does age matter?","volume":"33","author":"Hemmersbach-Miller","year":"2019","journal-title":"Clin Transplant"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.2215\/CJN.15040920","article-title":"Long-term immunosuppression management: opportunities and uncertainties.","volume":"16","author":"Wojciechowski","year":"2021","journal-title":"Clin J Am Soc Nephrol"},{"key":"R5-20250504","first-page":"CD006750","article-title":"Calcineurin inhibitor withdrawal or tapering for kidney transplant recipients.","volume":"7","author":"Karpe","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"e1003668","DOI":"10.1371\/journal.pmed.1003668","article-title":"Mycophenolate mofetil versus azathioprine in kidney transplant recipients on steroid-free, low-dose cyclosporine immunosuppression (ATHENA): A pragmatic randomized trial.","volume":"18","author":"Ruggenenti","year":"2021","journal-title":"PLoS Med"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1111\/j.1399-0012.2005.00421.x","article-title":"Impact of mycophenolate mofetil (MMF)-related gastrointestinal complications and MMF dose alterations on transplant outcomes and healthcare costs in renal transplant recipients.","volume":"19","author":"Tierce","year":"2005","journal-title":"Clin Transplant"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/aor.13623","article-title":"The latest modern and potent immunosuppressive drugs in adult kidney transplantation: What we should know about them?","volume":"44","author":"Bentata","year":"2020","journal-title":"Artif Organs"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1097\/FTD.0000000000000871","article-title":"Personalized therapy for mycophenolate: consensus report by the international association of therapeutic drug monitoring and clinical toxicology.","volume":"43","author":"Bergan","year":"2021","journal-title":"Ther Drug Monit"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"19379","DOI":"10.1038\/s41598-020-76379-6","article-title":"Initial mycophenolate dose in tacrolimus treated renal transplant recipients, a cohort study comparing leukopaenia, rejection and long-term graft function.","volume":"10","author":"Dave","year":"2020","journal-title":"Sci Rep"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1007\/s40262-019-00771-3","article-title":"Population pharmacokinetics of mycophenolic acid co-administered with tacrolimus in corticosteroid-free adult kidney transplant patients.","volume":"58","author":"Rong","year":"2019","journal-title":"Clin Pharmacokinet"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1016\/j.transproceed.2019.03.061","article-title":"Clinical significance of mycophenolate mofetil withdrawal in kidney transplant recipients.","volume":"51","author":"Park","year":"2019","journal-title":"Transplant Proc"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1097\/TP.0000000000002762","article-title":"Optimizing mycophenolic acid exposure in kidney transplant recipients: time for target concentration intervention.","volume":"103","author":"Metz","year":"2019","journal-title":"Transplantation"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/ajt.14625","article-title":"The Banff 2017 Kidney Meeting Report: Revised diagnostic criteria for chronic active T cell-mediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trials.","volume":"18","author":"Haas","year":"2018","journal-title":"Am J Transplant"},{"key":"R15-20250504","first-page":"216","article-title":"Early steroid withdrawal in a renal transplant cohort treated with tacrolimus, mycophenolate mofetil and basiliximab.","volume":"34","author":"Andrade-Sierra","year":"2014","journal-title":"Nefrologia"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.transproceed.2015.12.013","article-title":"Early steroid withdrawal in recipients of a kidney transplant from a living donor: experience of a single mexican center.","volume":"48","author":"Andrade-Sierra","year":"2016","journal-title":"Transplant Proc"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"20587384211000545","DOI":"10.1177\/20587384211000545","article-title":"Donor-specific antibodies development in renal living-donor receptors: effect of a single cohort.","volume":"35","author":"Andrade-Sierra","year":"2021","journal-title":"Int J Immunopathol Pharmacol"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"4617","DOI":"10.1177\/0300060518786917","article-title":"Differential profiles of adverse events associated with mycophenolate mofetil between adult and pediatric renal transplant patients.","volume":"46","author":"Hosohata","year":"2018","journal-title":"J Int Med Res"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/petr.13033","article-title":"Mycophenolate mofetil-related leukopenia in children and young adults following kidney transplantation: influence of genes and drugs.","volume":"21","author":"Varnell","year":"2017","journal-title":"Pediatr Transplant"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"128","DOI":"10.4103\/1319-2442.318514","article-title":"Impact of therapeutic dose monitoring of mycophenolic acid on the outcome of live-donor kidney transplant recipients - a Prospective Controlled Study.","volume":"32","author":"Denewar","year":"2021","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1111\/tri.13976","article-title":"Short- and long-term impact of neutropenia within the first year after kidney transplantation.","volume":"34","author":"Ingold","year":"2021","journal-title":"Transpl Int"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1097\/TP.0b013e318234e134","article-title":"Early steroid withdrawal and optimization of mycophenolic acid exposure in kidney transplant recipients receiving mycophenolate mofetil.","volume":"92","author":"Le Meur","year":"2011","journal-title":"Transplantation"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"E602","DOI":"10.1111\/ctr.12035","article-title":"Association of mycophenolic acid dose with efficacy and safety events in kidney transplant patients receiving tacrolimus: an analysis of the Mycophenolic acid Observational REnal transplant registry.","volume":"26","author":"Doria","year":"2012","journal-title":"Clin Transplant"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"e14671","DOI":"10.1111\/ctr.14671","article-title":"Tolerability of mycophenolate mofetil in elderly kidney transplant recipients: A retrospective cohort study.","volume":"36","author":"Witek","year":"2022","journal-title":"Clin Transplant"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1097\/TP.0b013e31817fdddb","article-title":"Effect on kidney graft survival of reducing or discontinuing maintenance immunosuppression after the first year posttransplant.","volume":"86","author":"Opelz","year":"2008","journal-title":"Transplantation"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1111\/bcp.13850","article-title":"Systematic external evaluation of published population pharmacokinetic models of mycophenolate mofetil in adult kidney transplant recipients co-administered with tacrolimus.","volume":"85","author":"Zhang","year":"2019","journal-title":"Br J Clin Pharmacol"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1111\/j.1399-0012.2008.00829.x","article-title":"Combination therapy with tacrolimus and mycophenolate mofetil: effects of early and late minimization of mycophenolate mofetil after renal transplant.","volume":"22","author":"Walker","year":"2008","journal-title":"Clin Transplant"},{"key":"R28-20250504","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1053\/j.ajkd.2007.11.013","article-title":"Incidence and risk factors for diarrhea following kidney transplantation and association with graft loss and mortality.","volume":"51","author":"Bunnapradist","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"R29-20250504","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1093\/ndt\/gfy377","article-title":"Effect of initial immunosuppression on long-term kidney transplant outcome in immunological low-risk patients.","volume":"34","author":"Michielsen","year":"2019","journal-title":"Nephrol Dial Transplant"},{"key":"R30-20250504","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1111\/tri.12382","article-title":"Do Asian renal transplant patients need another mycophenolate mofetil dose compared with Caucasian or African American patients?","volume":"27","author":"Li","year":"2014","journal-title":"Transpl Int"},{"key":"R31-20250504","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/FTD.0b013e31820271c3","article-title":"The pharmacokinetics of enteric-coated mycophenolate sodium and its gastrointestinal side effects in de novo renal transplant recipients of Hispanic ethnicity.","volume":"33","author":"Shah","year":"2011","journal-title":"Ther Drug Monit"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000035841","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T08:02:37Z","timestamp":1746345757000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000035841"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,17]]},"references-count":30,"journal-issue":{"issue":"46","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000035841","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"type":"print","value":"0025-7974"},{"type":"electronic","value":"1536-5964"}],"subject":[],"published":{"date-parts":[[2023,11,17]]}}}